Opus Genetics is trading 5.13% down at $4.34, with no specific catalyst identified for the October 5 decline.

  • A director-affiliated foundation sold 556,000 shares on September 30; the sale was disclosed October 2–3, but available reporting does not establish that it caused the move.
  • The broader indices provided are higher, so market direction does not explain the drop.